Post Categories
Promising Clinical Trial Results Suggest a Path Forward in Treating DMD
November 18, 2024
Duchenne muscular dystrophy (DMD) devastates young lives. This progressive disease, stemming from mutations in the gene that encodes the protein dystrophin, weakens muscles and…
Early Alzheimer’s Patients Benefit from Leqembi
November 13, 2024
Like many neurodegenerative diseases, early diagnosis and treatment of Alzheimer’s disease (AD) can greatly improve quality of life for individuals with the disease. Now,…
Sounding Out Disease: Using AI to Help Close the Diagnosis Gap for Millions with Tuberculosis
November 11, 2024
With millions of tuberculosis (TB) cases left undiagnosed each year due to limited healthcare access or incorrect diagnoses, researchers are turning to artificial intelligence…
Rezdiffra Gains Approval, Marks a New Chapter in Treating NASH (MASH) with Liver Scarring
November 4, 2024
The US Food and Drug Administration (FDA) has approved Rezdiffra™ (resmetirom), the first medication for treating patients with nonalcoholic steatohepatitis (NASH) with moderate to…
Exciting New Epilepsy Drug Reduces Seizures
October 30, 2024
Epilepsy affects as many as 50 million people worldwide, with a broad range of disease subtypes with limited treatment options. Fortunately, a new epilepsy…
Could Gene Therapy in Cows Slow Climate Change?
October 28, 2024
Despite the impact of companies like Impossible Foods, which markets plant-based imitation meat products, the demand for beef has never been higher. As of…
Weight Loss Drug Prescriptions Become More Accessible With Single-Dose Option
October 21, 2024
Eli Lilly has launched a new way for patients to access its popular weight loss drug, Zepbound® (tirzepatide). The company now offers single-dose vials…
Sizing Up Potential Medicare Costs of Covering Weight Loss Drugs for Heart Health
October 14, 2024
Medicare may soon face steeply increased prescription drug costs as it considers covering the popular weight loss drug, Wegovy® (semaglutide). Known for its ability…
Bispecific Antibody Drug Shows Cancer Treatment Potential
October 7, 2024
A new contender in the fight against lung cancer has emerged, with strong clinical trial results for ivonescimab, a bispecific antibody from partners Akeso…
Advancing CRISPR-Based Treatment for Rare Swelling Disease
September 30, 2024
Intellia Therapeutics, based in Cambridge, Massachusetts, reported promising results from the Phase II clinical trial of NTLA-2002, a CRISPR-based therapy targeting hereditary angioedema (HAE),…
Advancing Phase 3 Trials for ADC Cancer Therapies
September 25, 2024
Antibody-drug conjugates (ADCs) are being studied in various diseases, including cancer, autoimmune and infectious diseases. In cancer, ADCs are made up of a monoclonal…
Battling COVID in the Lab: Mini-Lungs Yield Insights and Potential Prevention Pathways
September 23, 2024
Over the past five years, scientists have slowly gained a better understanding of SARS-CoV-2, the virus responsible for the COVID-19 pandemic. Despite our knowledge…
Research Shows Coffee Drinkers May Enjoy Longer Lives
February 19, 2025
A fresh cup of coffee is a daily ritual for over 1 billion people around the world. Coffee isn’t just a morning treat; according…
Diet Changes to Slow Prostate Cancer? Omega-3 Study Has Promising Results
February 17, 2025
Men with early-stage prostate cancer may have a new tool to help slow disease progression. A Phase II trial led by researchers at the…
Gene Therapy Targets Mitochondria to Destroy Cancer Cells
February 10, 2025
Scientists have designed a new gene therapy strategy that uses an optogenetic approach to attack cancer cells from the inside. Optogenetics combines genetic engineering…
Squid-Inspired Microjet Device Could Enable More Direct Drug Delivery
February 3, 2025
A new type of drug delivery device in development could someday bypass the challenges and fears associated with certain types of injectable drugs. In…
Tiny Treadmills: Vampire Bats on the Go
January 29, 2025
In most mammals, the act of running is fueled primarily by the oxidization of carbohydrates and lipids, which are stored in the body as…
A Shot at Ending HIV: The Promise of Lenacapavir
January 27, 2025
HIV remains a global health crisis, infecting more than 1 million people annually. Although research has advanced to treat people who become infected, a…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
NEWARK, Delaware, November 13, 2024/BUSINESS WIRE/ — QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy…
